Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Replior AB

Clinicaltrial registered2 Nov 2026

Replior AB

2 Nov 2026: Trial registered · Observational Analytical Validation Study of the Replior ScratchSense. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
2 Nov 2026
Title
Observational Analytical Validation Study of the Replior ScratchSense
Conditions
Atopic Dermatitis, Pruritus, Chronic Pruritus of Unknown Origin
Study Type
Observational
Status
Recruiting
Countries
France
Country
France
Reference
NCT07909967
Location
France
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Replior AB

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from France

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.